Exploring the application of comprehensive genomic profiling in oncology therapy development

eurofins
America/Chicago UTC -5

Description

Comprehensive genomic profiling (CGP) is a method of testing that uses next-generation sequencing (NGS) to detect multiple genomic alterations (mutations and gene rearrangements) known to drive cancer growth. These alterations (biomarkers) have been shown to correlate with response to therapy, making them useful as an aid to more effective trial design and potentially improved outcomes.

 

What will you learn?

 

-What are comprehensive genomic profiles (CGP)?

-The four classes of genomic alterations known to drive cancer.

-How CGP can contribute to cancer diagnosis and the precision medicine approach to treatment decisions.

-How researchers are exploiting this technology to help reshape oncology trials and design more personalized therapies.

What are comprehensive genomic profiles (CGP)?, The four classes of genomic alterations known to drive cancer, How CGP can contribute to cancer diagnosis and the precision medicine approach to treatment decisions, How researchers are exploiting this technology to help reshape oncology trials and design more personalized therapies

Inglês

Previous registration necessary?

NO

YES
Simultaneous translation ?

NO

YES
Will it be recorded?
NO
YES
 

Speakers

Karina Eterovic

 
 
 
 

Download the Agenda

Search for our next event. See you soon!

Subscribe to get news on all upcoming events

who%20goals_edited.png

DocMeeetings

Social Media

  • Twitter DocMeetings
  • Instagram DocMeetings
  • Facebook ícone social
  • LinkedIn ícone social

contact us

Adress

Sao Paulo, SP - Brazil

© 2020 by Docmeetings - A DocMeetings.com Company
Site Managed by:
QUALITY Soluções Web
1996-2021 "25 years inspiring technology"